Dr. Fornoni is a tenured Professor of Medicine and Molecular and Cellular Pharmacology at the University of Miami Miller School of Medicine. She is the Chief of the Katz Family Division of Nephrology and Hypertension and serves as and Director and Chair of the Peggy and Harold Katz Drug Discovery Center. Dr. Fornoni gained experience in drug development at Hoffman-La Roche in Basel, and she is the funding scientist of several start-up companies. Her research is supported by grants from the NIH industry and private foundations. She has received prestigious awards: among them, she became a member of ASCI and AAP. Through her pioneering work on insulin signaling, cholesterol metabolism, and sphingolipid-related pathways, Dr. Fornoni uncovered novel pathogenetic mechanisms and therapeutic approaches for glomerular disorders. Her internationally recognized research findings, which are now being translated into humans with novel therapeutic applications, have challenged existing paradigms and have dramatically altered the research direction in these areas.
1 APRIL 2023
Time |
Session |
|
15:45
16:45
|
-
A Consensus Meeting to Guide Optimal Pre-clinical Animal Studies in Translational Nephrology
-
Insight Into CKDu Provided by the Global Kidney Health Atlas GKHA
Aminu Bello
Speaker
aminu1@ualberta.caUniversity of AlbertaCanada
-
Toolkits to Facilitate the Implementation and Update of Guidelines
-
Q and A
Plenary Halls 2 & 3
|
17:00
18:00
|
-
Acid-base and Electrolyte Abnormalities in Kidney Disease
-
Acute Kidney Injury Clinical, Drugs, AKI-CKD Continuum 2
-
Chronic Kidney Disease Complications (CVD, Hypertension, Anemia, BMD, Nutrition, Infection) 3
-
Chronic Kidney Disease Diagnosis, Classification and Progression 2
-
Chronic Kidney Disease, Experimental Models, Biomarkers, Precision Medicine 2
Wenjun Ju
Moderator
wenjunj@med.umich.eduUniversity Of Michigan Medical CenterUnited States
-
Clinical Glomerulonephritis 3
-
Covid-19 and CKD
-
Curriculum
-
Diabetic Kidney Disease, Drugs and Treatments 2
-
Epidemiology, Outcomes and Health Service Research Related to CKD or Its Complications 2
Sabine Karam
Moderator
Saint George Hospital University Medical CenterLebanon
-
Epidemiology, Outcomes and Health Services Research in Dialysis 2
-
Essential Hypertension and Renovascular Kidney Disease
Barry Freedman
Moderator
Wake Forest University School of Medicine United States
-
Genetics and Epigenetics (Including Common and Rare Genetic Diseases)
Chairat Shayakul
Moderator
Faculty of Medicine Siriraj Hospital, THAILANDThailand
-
Haemodialysis, Haemodiafiltration and Vascular Access 2
-
Haemodialysis, Haemodiafiltration and Vascular Access 3
Jonathan Himmelfarb
Moderator
jhimmelfarb@nephrology.washington.eduKidney Research Institute, University of Washington United States
-
Inflammation, Fibrosis, Matrix Biology and Oxidative Stress
Youhua LIU
Moderator
University of PittsburghUnited States
-
Kidney Transplantation and Transplant Immunology 3
Narayan Prasad
Moderator
Sanjay Gandhi Post Graduate Institute of Medical SIndia
-
Kidney Transplantation and Transplant Immunology 4
-
Late Breaking Clinical Trials
-
Nephrotic Syndrome
-
Other CKD 2
Jie Dong
Moderator
jie.dong@bjmu.edu.cnPeking University First HospitalChina
-
Other KF (Kidney Failure)
Tai Shuan Lai
Moderator
National Taiwan University HospitalTaiwan
-
Peritoneal Dialysis 2
-
Peritoneal Dialysis 3
-
Training
-
Tropical Kidney Diseases (Viral Nephropathies, TB, Schistosomiasis, Malaria, Leptospirosis, Animal Venoms)
-
Urologic Disorders
-
Vascular Biology and Endothelial Function
Reiko Inagi
Moderator
Univ of Tokyo - Grad. School of MedicineJapan
Ballroom 2-3-4-Exhibition Hall
|
2 APRIL 2023
Time |
Session |
|
08:30
10:00
|
-
CKD with Diabetes vs. Diabetic Nephropathy
-
Treatment 1 (SGLT2, GLP1)
-
Treatment 2 (Finrenone, etc.)
-
Prevention of DKD
Juliana Chan
Speaker
The Chinese University of Hong KongHong Kong, China
-
Q and A
Plenary Hall 1
|